Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fay

Showing results (301-310 of 395) with videos related to

Pageof 40
Sort By:
Clinical Genitourinary Cancer|April 3, 2016
Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell CarcinomaKathleen M Mahoney, Susanna Jacobus, Rupal S Bhatt, et al.
Blood|June 3, 2010
Endothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasisThomas A White, Tucker Johnson, Natalia Zarzhevsky, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa InfectionJesica A Herrick, Fanny Legrand, Raceline Gounoue, et al.
Molecular Cancer Therapeutics|October 27, 2019
Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell CarcinomaAmin H Nassar, Lana Hamieh, Kathryn P Gray, et al.
Plos One|August 14, 2008
Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malariaGregory E D Mullen, Ruth D Ellis, Kazutoyo Miura, et al.
The American Journal of Tropical Medicine and Hygiene|October 5, 2010
Comparing the understanding of subjects receiving a candidate malaria vaccine in the United States and MaliRuth D Ellis, Issaka Sagara, Anna Durbin, et al.
Plos One|July 31, 2008
Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responsesJeffrey A Lyon, Evelina Angov, Michael P Fay, et al.
Vaccine|January 7, 2010
Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adultsMark A Pierce, Ruth D Ellis, Laura B Martin, et al.
Frontiers in Cardiovascular Medicine|April 18, 2022
CagA<sup>+</sup> <i>Helicobacter pylori</i>, Not CagA<sup>-</sup> <i>Helicobacter pylori</i>, Infection Impairs Endothelial Function Through Exosomes-Mediated ROS FormationXiujuan Xia, Linfang Zhang, Hao Wu, et al.
The Journal of Allergy and Clinical Immunology|November 11, 2023
Mepolizumab incompletely suppresses clinical flares in a pilot study of episodic angioedema with eosinophiliaPaneez Khoury, Michelle A Makiya, Rodaba Rahim, et al.
Pageof 40

Showing results (301-310 of 395) with videos related to

Sort By:
Pageof 40
Clinical Genitourinary Cancer|April 3, 2016
Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell CarcinomaKathleen M Mahoney, Susanna Jacobus, Rupal S Bhatt, et al.
Blood|June 3, 2010
Endothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasisThomas A White, Tucker Johnson, Natalia Zarzhevsky, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa InfectionJesica A Herrick, Fanny Legrand, Raceline Gounoue, et al.
Molecular Cancer Therapeutics|October 27, 2019
Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell CarcinomaAmin H Nassar, Lana Hamieh, Kathryn P Gray, et al.
Plos One|August 14, 2008
Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malariaGregory E D Mullen, Ruth D Ellis, Kazutoyo Miura, et al.
The American Journal of Tropical Medicine and Hygiene|October 5, 2010
Comparing the understanding of subjects receiving a candidate malaria vaccine in the United States and MaliRuth D Ellis, Issaka Sagara, Anna Durbin, et al.
Plos One|July 31, 2008
Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responsesJeffrey A Lyon, Evelina Angov, Michael P Fay, et al.
Vaccine|January 7, 2010
Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adultsMark A Pierce, Ruth D Ellis, Laura B Martin, et al.
Frontiers in Cardiovascular Medicine|April 18, 2022
CagA<sup>+</sup> <i>Helicobacter pylori</i>, Not CagA<sup>-</sup> <i>Helicobacter pylori</i>, Infection Impairs Endothelial Function Through Exosomes-Mediated ROS FormationXiujuan Xia, Linfang Zhang, Hao Wu, et al.
The Journal of Allergy and Clinical Immunology|November 11, 2023
Mepolizumab incompletely suppresses clinical flares in a pilot study of episodic angioedema with eosinophiliaPaneez Khoury, Michelle A Makiya, Rodaba Rahim, et al.
Pageof 40